MARKET

ONCO

ONCO

Onconetix
NASDAQ
1.110
+0.080
+7.77%
Closed 16:00 09/28 EDT
OPEN
1.190
PREV CLOSE
1.030
HIGH
1.360
LOW
1.050
VOLUME
22.30M
TURNOVER
--
52 WEEK HIGH
209.50
52 WEEK LOW
0.5859
MARKET CAP
4.86M
P/E (TTM)
-0.0055
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 3d ago
5 Biotech Stocks Making Headlines - ADRX, CNSY, JAGX, AGL, ONCO
NASDAQ · 3d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 3d ago
Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
SRX Global Liquidates 2 Portfolio Investments, Adds Onconetix Ahead Of Realbotix Deal
NASDAQ · 3d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 4d ago
SRX Global says adds investment in Onconetix
TipRanks · 4d ago
More
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Webull offers Onconetix Inc stock information, including NASDAQ: ONCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCO stock methods without spending real money on the virtual paper trading platform.